CIK 0001572616
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
FRACTYL HEALTH, INC.
Sign in to watch- Ticker
- GUTS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273553477
- Phone
- +1 781-902-8800
- Business address
- 3 VAN DE GRAAFF DRIVE, SUITE 200, BURLINGTON, MA, 01803
- Former names
- Fractyl Laboratories Inc.
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Executive Officer sold 111,920 shares at an average $1.84 ($206,003)
- 4 Planned sale President, Chief Product Off. sold 43,818 shares at an average $1.88 ($82,266)
- 4 Open-market sale Chief Executive Officer sold 96,517 shares at $2.47 ($238,358)
- 4 Open-market sale President, Chief Product Off. sold 64,197 shares at $2.47 ($158,541)
- 4 Open-market sale President, Chief Product Off. sold 65,000 shares at $2.90 ($188,474)
- 3/A Insider 3/A
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Conversion 10% owner acquired 4,770,901 shares (conversion)
- 4 Conversion 10% owner acquired 1,339,261 shares (conversion)
- 4 Conversion 10% owner acquired 673,391 shares (conversion)
- 4 Conversion 10% owner acquired 283,878 shares (conversion)
- 4 Conversion Director acquired 277,890 shares (conversion)
- 4 Open-market buy Director bought 333,333 shares at $15.00 ($4,999,995)
- 4 Conversion President, Chief Product Off. acquired 142,109 shares (conversion)
- 4 Conversion Chief Executive Officer acquired 9,318 shares (conversion)
- 4 Open-market buy 10% owner bought 333,333 shares at $15.00 ($4,999,995)
- 4 Conversion 10% owner acquired 4,800,310 shares (conversion)
- 4 Open-market buy Director bought 466,666 shares at $15.00 ($6,999,990)
Page 3 of 5 · 91 filings